Trial Profile
A prospective , non-interventional, italian observational study of cetuximab based regimen as first line therapy in metastatic colorectal cancer patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Acronyms ObservEr study
- 31 Aug 2015 New trial record